Products
4-(1H-pyrrol-1-yl)phenol
  • 4-(1H-pyrrol-1-yl)phenol4-(1H-pyrrol-1-yl)phenol

4-(1H-pyrrol-1-yl)phenol

Model: 23351-09-9
4-(1H-pyrrol-1-yl)phenol is a bifunctional aromatic compound featuring an electron-rich pyrrole heterocycle linked to the para position of a phenol group. This unique donor–acceptor architecture (the pyrrole nitrogen donating into the phenol π-system) governs its reactivity profile and biological potential. The electron-donating hydroxyl group modulates the electronic environment of the entire conjugated system, while the pyrrole ring’s NH-like character (though substituted at nitrogen) retains significant π-excess density. Together, these features position this compound as a highly adaptable scaffold in medicinal chemistry, organic electronics, and materials science.

4-(1H-Pyrrol-1-yl)phenol (CAS 23351-09-9), also known as 4-pyrrolylphenol or N-(4-hydroxyphenyl)pyrrole, is a heterocyclic aromatic building block consisting of a phenol group attached to a pyrrole ring at the para position. Its structure features a pyrrole ring that contributes to its potential biological activity, while the hydroxyl group enhances its reactivity and hydrogen-bonding capabilities.

The compound typically appears as a cream to light brown powder or colorless to pale yellow solid, with a melting point of 119–122°C and a molecular weight of 159.18 g/mol. Its bifunctional nature enables broad applicability: the electron-rich pyrrole ring undergoes electrophilic substitution and participates in π-conjugated systems, while the phenolic OH provides a handle for esterification, etherification, and hydrogen-bonding interactions.

In medicinal chemistry, 4-(1H-Pyrrol-1-yl)phenol serves as the core scaffold for generating pharmacologically active molecules. A recent study synthesized a series of new 4-(1H-pyrrol-1-yl)phenyl benzoates via reaction of 4-(1H-Pyrrol-1-yl)phenol with substituted benzoyl chlorides, and these derivatives exhibited significant antimicrobial and antitubercular activities with minimum inhibitory concentration values ranging from 0.8 to 12.5 µg/mL. Moreover, 4-(1H-Pyrrol-1-yl)phenol derivatives have been incorporated into ferrocene complexes as potential chemotherapeutic drugs, with moderate anti-proliferative activity observed against the MCF-7 breast cancer cell line.

In materials science, 4-(1H-Pyrrol-1-yl)phenol has been copolymerized with pyrrole to form a cathode material for Li-ion batteries, with the resulting P(PLPY-co-Py) demonstrating a significantly improved specific capacity of 73.9 mAh·g⁻¹ compared to 21.4 mAh·g⁻¹ for pure polypyrrole. This combination of a para-phenol and an N-linked pyrrole provides a unique balance of nucleophilicity, oxidative stability, and conjugation not found in simpler substituted phenols or pyrroles.


Product Parameters

Parameter

Specification

CAS Number

23351-09-9

Molecular Formula

C₁₀H₉NO

Molecular Weight

159.18 g/mol

Purity

≥95% (NMR/HPLC); ≥98% available upon request

Appearance

Cream to light brown powder or colorless to pale yellow solid

Melting Point

119–122°C (lit.)

Boiling Point

301.8 ± 25.0°C (Predicted)

Density

1.10 ± 0.1 g/cm³ (Predicted)

pKa

9.09 ± 0.26 (Predicted)

SMILES

OC1=CC=C(C=C1)N2C=CC=C2

Storage Condition

Sealed in dry, room temperature

Form

Powder

HS Code

29339980

Hazard Symbols

Xi, Xn

Hazard Codes

36/37/38 – 20/21/22

Safety Statements

26 – 36 – 36/37/39


Product Advantages

1.Bifunctional architecture – Combines an electron-rich pyrrole ring (a privileged structure in drug discovery) with a phenolic OH group, enabling dual reactivity patterns: the OH supports esterification, etherification, and hydrogen bonding, while the pyrrole participates in π-conjugated systems and electrophilic substitution.

2.Biologically privileged scaffold – Derivatives have demonstrated significant antimicrobial, antitubercular, and antifungal activities. When incorporated into ferrocene complexes, they exhibit moderate anti-proliferative activity against breast cancer cells (MCF-7).

3.Energy storage potential – Copolymers with pyrrole show specific capacity of 73.9 mAh·g⁻¹ as Li-ion battery cathode materials, significantly higher than pure polypyrrole (21.4 mAh·g⁻¹).

4.Aldose reductase inhibition – The fluorinated derivative has been identified as a submicromolar aldose reductase inhibitor (IC50 = 0.443 µM) with favorable membrane permeation (pKa 7.64).

5. High purity – ≥95% as standard; ≥98% available upon request, with single impurity ≤0.5% and total impurities ≤1.0%.


Synthetic Routes

Several methods have been documented for the synthesis of 4-(1H-Pyrrol-1-yl)phenol:

Method 1: Modified Clauson–Kaas Reaction

A reliable approach involves the reaction of 4-aminophenol with 2,5-dimethoxytetrahydrofuran under acidic conditions. The di-carbonyl equivalent cyclizes with the primary amine to form the pyrrole ring directly onto the aromatic scaffold. This one-step method is convenient for laboratory-scale synthesis and has been used to prepare a series of p-substituted N-phenylpyrroles.


Method 2: Palladium-Catalyzed Cross-Coupling

Ullmann-type coupling enables the direct N-arylation of pyrrole with 4-bromophenol or 4-iodophenol in the presence of a palladium or copper catalyst. The reaction typically occurs under mild conditions and may require a solvent such as ethanol or methanol.


Method 3: Copper-Catalyzed Synthesis

Alternatively, the reaction of 4-chlorophenol with pyrrole in the presence of a copper catalyst provides another synthetic pathway. The efficiency and yield of each method vary depending on the reaction conditions and the purity of starting materials.


Frequently Asked Questions (FAQ)

Q1: What are the primary applications of 4-(1H-Pyrrol-1-yl)phenol?

A: This compound is a versatile building block used in several fields: medicinal chemistry (antimicrobial, antitubercular, anticancer research), materials science (conductive polymers, Li-ion battery cathodes), and organic synthesis (ligands for metal complexes, precursors for functional materials).


Q2:What biological activities have been reported for derivatives of this compound?

A: Derivatives have demonstrated significant antimicrobial and antitubercular activities with MIC values ranging from 0.8 to 12.5 µg/mL. Derivatives have also shown antifungal activity against Candida species and moderate anti-proliferative activity against the MCF-7 breast cancer cell line when incorporated into ferrocene complexes. The fluorinated derivative (2-fluoro-4-(1H-pyrrol-1-yl)phenol) is a potent aldose reductase inhibitor (IC50 = 0.443 µM).


Contact Us

Cosperpharm – your trusted partner for high-purity heterocyclic building blocks.We welcome all scientific and commercial inquiries. Whether you need a sample for method development, a quote for bulk production, or technical support for your research project, our team is ready to assist.


Send Inquiry
Contact Info
For inquiries about our products or pricelist, please leave your email to us and we will be in touch within 24 hours.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
RejectAccept